[1] Paini M, Crippa S, Partelli S, et al.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas[J]. World J Gastroenterol,2014,20(29):10008-10023.
[2] Takagi K, Oota H, Ohhashi I, et al.Diagnostic ability and limitation of ERCP for pancreatic cancer[J]. Stomach Intestine,1982,17(8):1065-1080.
[3] 匡天涛, 靳大勇. 胰腺导管内乳头状黏液性肿瘤的诊断与治疗[J]. 外科理论与实践,2011,16(5):429-431.
[4] Limaiem F, Khalfallah T, Farhat LB, et al.Pancreatic cystic neoplasms[J]. N Am J Med Sci,2014,6(8):413-417.
[5] Clores MJ, Thosani A, Buscaglia JM.Multidisciplinary diagnostic and therapeutic approaches to pancreatic cystic lesions[J]. J Multidiscip Healthc,2014,7:81-91.
[6] Piciucchi M, Crippa S, Del Chiaro M, et al.Outcomes of intraductal papillary mucinous neoplasm with “Sendai-positive” criteria for resection undergoing non-operative management[J]. Dig Liver Dis,2013,45(7):584-588.
[7] Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas[J]. Pancrea-tology,2017,17(5):738-753.
[8] 张家强, 詹茜, 彭承宏. 胰腺导管内乳头状粘液性肿瘤诊治相关进展[J]. 现代生物医学进展,2013,13(23):4587-4590.
[9] 廖佳桦, 贾明库, 张鹏, 等. 胰腺导管内乳头状黏液性肿瘤的诊疗现状[J]. 癌症进展,2016,14(7):616-619.
[10] Fritz S, Küper-Steffen R, Feilhauer K, et al.Resection of benign side-branch intraductal papillary mucinous neoplasm of the pancreas-is long term follow-up indicated?: A case report and review of the literature[J]. Medicine(Baltimore),2018,97(7):e9894-e9897.
[11] 梁廷波, 白雪莉, 马涛. 胰腺囊性肿瘤诊治的困惑与对策[J]. 中国实用外科杂志,2018,38(1):48-52.
[12] Fong ZV, Alvino DM, Castillo CF, et al.Health-related quality of life and functional outcomes in 5-year survivors after pancreaticoduodenectomy[J]. Ann Surg,2017,266(4):685-692.
[13] Marchegiani G, Mino-Kenudson M, Ferrone CR, et al.Patterns of recurrence after resection of IPMN: who, when, and how?[J]. Ann Surg,2015,262(6):1108-1114.
[14] 侯建芳, 丁伟, 孙卫国. 胰腺导管内乳头状黏液性肿瘤的诊断与治疗[J]. 肝胆胰外科杂志,2018,30(2):167-169.
[15] 杨玉龙. 胆胰汇合部疾病的临床思考和诊治策略[J]. 外科理论与实践,2015,20(2):102-107.
[16] Käppeli RM, Müller SA, Hummel B, et al.IPMN: surgical treatment[J]. Langenbecks Arch Surg,2013,398(8):1029-1037.
[17] 王尧, 王雷, 范向军, 等.胰腺导管内乳头状粘液肿瘤32例临床分析[J]. 交通医学,2015,29(6):596-598.
[18] 杨蕾, 张斌, 李长锋, 等. 内镜诊治胰腺导管内乳头状粘液性肿瘤的应用[J]. 临床肝胆病杂志,2012,28(2):108-110.
[19] Chin JY, Pitman MB, Hong TS.Intraductal papillary mucinous neoplasm: clinical surveillance and management decisions[J]. Semin Radiat Oncol,2014,24(2):77-84.
[20] 刘庆, 蒋建霞. 内镜技术在胰腺导管内乳头状黏液性肿瘤诊疗中的研究进展[J]. 世界华人消化杂志,2014, 22(23):3416-3423.
[21] 张迎春, 麻树人, 杨卓, 等. 1 158例高龄胰胆疾病患者临床特征及内镜诊疗效果分析[J]. 中华消化内镜杂志,2014,31(3):143-147.
[22] 毕军, 周鸿鲲, 钟征翔, 等. 胰管支架在老年胰腺导管内乳头状黏液瘤患者中的应用[J]. 全科医学临床与教育,2012,10(3):289-290.
[23] 张诚, 杨玉龙, 吴萍, 等. 内镜下胰管支架置入术后支架内移位的处理[J]. 中华肝胆外科杂志,2014,20(12):866-868.
[24] Zhang C, Yang YL, Ma YF, et al.The modified pancrea-tic stent system for prevention of post-ERCP pancreatitis: a case-control study[J]. BMC Gastroenterol,2017,17(1):108-115.
[25] Ohtsuka T, Ideno N, Aso T, et al.Role of endoscopic retrograde pancreatography for early detection of pancrea-tic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas[J]. J Hepatobiliary Pancreat Sci,2013,20(3):356-361.
[26] Yoshioka T, Shigekawa M, Yamai T, et al.The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients[J]. Pancreatology,2016,16(6):1020-1027.
[27] 姜蕾, 令狐恩强, 李惠凯, 等. SpyGlass系统在胰腺囊性肿瘤诊断中的应用[J]. 中华胃肠内镜电子杂志,2016,3(1):33-36.
[28] 吴静静, 顾红祥, 张亚历. 直接经口胆道镜诊治胆道疾病的临床进展[J]. 现代消化及介入诊疗,2018,23(1):131-134.
[29] Chen YK.Preclinical characterization of the Spyglass peroral cholangiopancreatoscopy system for direct access, visualization, and biopsy[J]. Gastrointest Endosc,2007, 65(2):303-311.
[30] Kurihara T, Yasuda I, Isayama H, et al.Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: Prospective multicenter study in Japan[J]. World J Gastroenterol,2016,22(5):1891-1901.
[31] Hara T, Yamaguchi T, Ishihara T, et al.Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography[J]. Gastroenterology,2002,122(1):34-43.
[32] Arnelo U, Siiki A, Swahn F, et al.Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms(IPMN)[J]. Pancreatology,2014,14(6):510-514.
[33] Hammerle CW, Haider S, Chung M, et al.Endoscopic retrograde cholangiopancreatography complications in the era of cholangioscopy: is there an increased risk?[J]. Dig Liver Dis,2012,44(9):754-758.
[34] Yang JF, Sharaiha RZ, Francis G, et al.Diagnostic accuracy of directed cholangioscopic biopsies and confocal laser endomicroscopy in cytology-negative indeterminate bile duct stricture: a multicenter comparison trial[J]. Mi-nerva Gastroenterol Dietol,2016,62(3):227-233.
[35] Konda VJ, Aslanian HR, Wallace MB, et al.First assessment of needle-based confocal laser endomicroscopy during EUS-FNA procedures of the pancreas (with videos)[J]. Gastrointest Endosc,2011,74(5):1049-1060.
[36] Konda VJ, Meining A, Jamil LH, et al.A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance[J]. Endoscopy,2013,45(12):1006-1013.
[37] Nakai Y, Iwashita T, Park DH, et al.Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study[J]. Gastrointest Endosc,2015,81(5):1204-1214.
[38] Lensing RJ, Bipat S.Incidences of pancreatic malignancy and mortality in patients with untreated branch-duct intraductal papillary mucinous neoplasms undergoing surveillance: a systematic review[J]. Pancreas,2017,46(9):1098-1110.
[39] Vanella G, Crippa S, Archibugi L, et al.Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation[J]. Br J Surg,2018, 105(4):328-338.
